184 related articles for article (PubMed ID: 24928521)
1. Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.
Schröder-Heurich B; Bogdanova N; Wieland B; Xie X; Noskowicz M; Park-Simon TW; Hillemanns P; Christiansen H; Dörk T
BMC Cancer; 2014 Jun; 14():434. PubMed ID: 24928521
[TBL] [Abstract][Full Text] [Related]
2. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.
Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J
Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123
[TBL] [Abstract][Full Text] [Related]
3. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
[TBL] [Abstract][Full Text] [Related]
5. The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients.
di Masi A; Viganotti M; Polticelli F; Ascenzi P; Tanzarella C; Antoccia A
Biochem Biophys Res Commun; 2008 May; 369(3):835-40. PubMed ID: 18328813
[TBL] [Abstract][Full Text] [Related]
6. Hsp90α regulates ATM and NBN functions in sensing and repair of DNA double-strand breaks.
Pennisi R; Antoccia A; Leone S; Ascenzi P; di Masi A
FEBS J; 2017 Aug; 284(15):2378-2395. PubMed ID: 28631426
[TBL] [Abstract][Full Text] [Related]
7. DNA repair functional analyses of NBN hypomorphic variants associated with NBN-related infertility.
Fiévet A; Bellanger D; Zahed L; Burglen L; Derrien AC; Dubois d'Enghien C; Lespinasse J; Parfait B; Pedespan JM; Rieunier G; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2020 Mar; 41(3):608-618. PubMed ID: 31729086
[TBL] [Abstract][Full Text] [Related]
8. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Desjardins S; Beauparlant JC; Labrie Y; Ouellette G; Durocher F;
BMC Cancer; 2009 Jun; 9():181. PubMed ID: 19523210
[TBL] [Abstract][Full Text] [Related]
9. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
11. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
[TBL] [Abstract][Full Text] [Related]
13. Distinct kinetics of DNA repair protein accumulation at DNA lesions and cell cycle-dependent formation of γH2AX- and NBS1-positive repair foci.
Suchánková J; Kozubek S; Legartová S; Sehnalová P; Küntziger T; Bártová E
Biol Cell; 2015 Dec; 107(12):440-54. PubMed ID: 26482424
[TBL] [Abstract][Full Text] [Related]
14. Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
Eich M; Roos WP; Dianov GL; Digweed M; Kaina B
Mol Pharmacol; 2010 Nov; 78(5):943-51. PubMed ID: 20729302
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women.
Mateju M; Kleiblova P; Kleibl Z; Janatova M; Soukupova J; Ticha I; Novotny J; Pohlreich P
Breast Cancer Res Treat; 2012 Jun; 133(2):809-11. PubMed ID: 22491912
[No Abstract] [Full Text] [Related]
16. Fertility defects revealing germline biallelic nonsense NBN mutations.
Warcoin M; Lespinasse J; Despouy G; Dubois d'Enghien C; Laugé A; Portnoï MF; Christin-Maitre S; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2009 Mar; 30(3):424-30. PubMed ID: 19105185
[TBL] [Abstract][Full Text] [Related]
17. Nbn and atm cooperate in a tissue and developmental stage-specific manner to prevent double strand breaks and apoptosis in developing brain and eye.
Rodrigues PM; Grigaravicius P; Remus M; Cavalheiro GR; Gomes AL; Rocha-Martins M; Frappart L; Reuss D; McKinnon PJ; von Deimling A; Martins RA; Frappart PO
PLoS One; 2013; 8(7):e69209. PubMed ID: 23935957
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.
Zuhlke KA; Johnson AM; Okoth LA; Stoffel EM; Robbins CM; Tembe WA; Salinas CA; Zheng SL; Xu J; Carpten JD; Lange EM; Isaacs WB; Cooney KA
Fam Cancer; 2012 Dec; 11(4):595-600. PubMed ID: 22864661
[TBL] [Abstract][Full Text] [Related]
19. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.
Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ
Cancer Res; 2003 Nov; 63(21):7263-9. PubMed ID: 14612522
[TBL] [Abstract][Full Text] [Related]
20. Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
Suspitsin EN; Yanus GA; Sokolenko AP; Yatsuk OS; Zaitseva OA; Bessonov AA; Ivantsov AO; Heinstein VA; Klimashevskiy VF; Togo AV; Imyanitov EN
Med Oncol; 2014 Feb; 31(2):828. PubMed ID: 24415413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
